What if the fix for long COVID brain fog has been sitting in your pharmacy for decades, costing pennies a pill?

A landmark trial tracking 399 people crushed by chronic, post-viral exhaustion just dropped in the Annals of Internal Medicine. Researchers tested a cheap generic antidepressant, Fluvoxamine, against Metformin and a placebo.

Metformin failed so badly that researchers stopped giving it to patients partway through the trial. Fluvoxamine, on the other hand, significantly cut fatigue scores, and the benefit held steady all the way through day 90. Researchers found a 99% statistical probability it outperformed placebo.

🧬 Why it works
This has nothing to do with depression or serotonin. Long COVID triggers a hidden wildfire of inflammation inside brain cells. Fluvoxamine is a potent agonist of the Sigma-1 receptor, a cellular “master key” that helps quench that inflammation and protect cells from post-viral burnout. This trial didn’t test the mechanism directly, but it’s the leading explanation for why this cheap drug is outperforming the alternatives.

💊 The part that surprised me most
Fluvoxamine actually had fewer side effects than the placebo pill in this trial. So if a $4-a-month generic beats a diabetes drug, and does it more safely, what’s stopping it from becoming standard of care?

👇 If you're a clinician or patient dealing with long COVID: what do you think is holding this drug back from wider use? Genuinely want to hear different takes on this.